Literature DB >> 21153720

Management strategies for patients with low-risk chest pain in the emergency department.

Maame Yaa A B Yiadom1, Joshua M Kosowsky.   

Abstract

OPINION STATEMENT: There is abundant evidence to guide the management of chest pain patients with a confirmed or reasonably suspected diagnosis of acute coronary syndrome (ACS). But when it comes to the low-risk chest pain patient in the emergency department, there is limited evidence to support one approach over another. As a result, the evaluation of low-risk chest pain represents a distinct challenge for the emergency physician. Missing a diagnosis of ACS is certainly undesirable. However, the overuse of technology can result in misleading test results in populations with a low incidence of coronary disease. In this article, we dispel several myths surrounding low-risk chest pain and put forward a number of common-sense recommendations. We endorse taking a focused but thorough chest pain history; encourage the use of serial electrocardiogram, particularly for patients with ongoing or changing symptoms; comment on the interpretation of cardiac biomarkers in the era of highly sensitive troponin assays, drawing a distinction between myocardial injury and myocardial infarction; discuss the role of coronary computed tomography angiography as a test for coronary artery disease, rather than for ACS; and caution against the reflexive use of provocative testing in low-risk chest pain patients.

Entities:  

Year:  2011        PMID: 21153720     DOI: 10.1007/s11936-010-0108-3

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  39 in total

1.  MYOCARDIAL INFARCTION. CLINICAL FEATURES AND OUTCOME IN THREE THOUSAND THIRTY-SIX CASES.

Authors:  J SIEVERS
Journal:  Acta Med Scand       Date:  1964

2.  Clinical policy: critical issues in the evaluation and management of adult patients with non-ST-segment elevation acute coronary syndromes.

Authors:  Francis M Fesmire; Wyatt W Decker; Deborah B Diercks; Chris A Ghaemmaghami; Devorah Nazarian; William J Brady; Sigrid Hahn; Andy S Jagoda
Journal:  Ann Emerg Med       Date:  2006-09       Impact factor: 5.721

Review 3.  Coronary CT angiography.

Authors:  Udo Hoffmann; Maros Ferencik; Ricardo C Cury; Antonio J Pena
Journal:  J Nucl Med       Date:  2006-05       Impact factor: 10.057

4.  Initial ECG in Q wave and non-Q wave myocardial infarction.

Authors:  F M Fesmire; R F Percy; R L Wears; T L MacMath
Journal:  Ann Emerg Med       Date:  1989-07       Impact factor: 5.721

5.  Exercise echocardiography or exercise SPECT imaging? A meta-analysis of diagnostic test performance.

Authors:  K E Fleischmann; M G Hunink; K M Kuntz; P S Douglas
Journal:  JAMA       Date:  1998-09-09       Impact factor: 56.272

6.  Comprehensive strategy for the evaluation and triage of the chest pain patient.

Authors:  J L Tatum; R L Jesse; M C Kontos; C S Nicholson; K L Schmidt; C S Roberts; J P Ornato
Journal:  Ann Emerg Med       Date:  1997-01       Impact factor: 5.721

7.  Cost-effectiveness of mandatory stress testing in chest pain center patients.

Authors:  M G Mikhail; F A Smith; M Gray; C Britton; S M Frederiksen
Journal:  Ann Emerg Med       Date:  1997-01       Impact factor: 5.721

8.  Clinical evaluation of the first medical whole blood, point-of-care testing device for detection of myocardial infarction.

Authors:  F S Apple; F P Anderson; P Collinson; R L Jesse; M C Kontos; M A Levitt; E A Miller; M M Murakami
Journal:  Clin Chem       Date:  2000-10       Impact factor: 8.327

9.  The limited utility of routine cardiac stress testing in emergency department chest pain patients younger than 40 years.

Authors:  Luke K Hermann; Scott D Weingart; W Lane Duvall; Milena J Henzlova
Journal:  Ann Emerg Med       Date:  2009-02-23       Impact factor: 5.721

10.  A decision tree for the early diagnosis of acute myocardial infarction in nontraumatic chest pain patients at hospital admission.

Authors:  J Mair; J Smidt; P Lechleitner; F Dienstl; B Puschendorf
Journal:  Chest       Date:  1995-12       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.